T-1330 is a pharmaceutical intermediate featuring a triazolone core linked to a piperazine-substituted phenyl group and a hydroxyphenyl group. It is primarily used in the research and manufacturing of active pharmaceutical ingredients.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing T-1330?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-sec-butyl-4-(4-(4-(4-methoxyphenyl)piperazin-1-yl)phenyl)-2H-1,2,4-triazol-3(4H)-one
pharmaceutical intermediate
2-Bromo-4-fluoro-5-methylbenzenamine
pharmaceutical intermediate
Trimethylsilylacetylene
pharmaceutical intermediate
Methyl 2,4-difluorobenzoate
pharmaceutical intermediate
N-Sulphamyl-3-chloropropionamidine hydrochloride
pharmaceutical intermediate
The international HS code for T-1330 (CAS 106461-41-0) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-butan-2-yl-4-[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]-1,2,4-triazol-3-one
FFAQILVGBAELHN-UHFFFAOYSA-N
CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)O
Sourcing T-1330?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.